TVTX

Travere Therapeutics Inc (TVTX)

US
$ 18.32993.97%

Price Chart

Key Statistics

Market Cap
$ 1.51B
P/E Ratio
0.00
Revenue (TTM)
$ 273.53M
Volume
1.32M
52W High
$ 25.29
52W Low
$ 6.14
Dividend Yield
0.00%
Beta
0.88

Technicals

50-Day MA
18.4433
200-Day MA
17.0664
52 Week High
25.29
52 Week Low
6.14

About TVTX

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Employees
385
Headquarters
San Diego, CA
CEO
Dr. Eric M. Dube Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
BLMZ
BloomZ Inc. Ordinar...
$ 0.24
136.74
EDBL
Edible Garden AG In...
$ 3.82
91.00
TNMG
TNL Mediagene Ordin...
$ 1.03
72.85
SYTA
Siyata Mobile Inc. ...
$ 6.75
65.85
NRXS
Neuraxis Inc. Commo...
$ 3.76
65.64

Top Losers

Symbol/Name
LTP
% Chg
PTIX
Protagenic Therapeu...
$ 6.15
-44.59
NWTN
NWTN Inc. Class B O...
$ 2.34
-23.53
KIDZ
Classover Holdings ...
$ 2.70
-11.48
BCLI
Brainstorm Cell The...
$ 1.22
-10.29
TGL
Treasure Global Inc...
$ 1.62
-10.00